APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artificial Intelligence Diagnostics Market Outlook and Growth Opportunities 2026

Report ID 174069800415 January 2026210 pages

Choose your research edition.

Industry ResearchArtificial Intelligence Diagnostics Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence Diagnostics Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence Diagnostics Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence Diagnostics Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Artificial Intelligence Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artificial Intelligence Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artificial Intelligence Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artificial Intelligence Diagnostics market include Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical and BrainMiner, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Artificial Intelligence Diagnostics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Intelligence Diagnostics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Intelligence Diagnostics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Artificial Intelligence Diagnostics market.

Artificial Intelligence Diagnostics Segment by Company

Butterfly Network

Merative

Tempus

RetinAi

Nanox

Lunit

DiA Imaging

Subtle Medical

BrainMiner

GE

Siemens

Aidoc

Imagen Technologies, Inc.

VUNO, Inc.

Digital Diagnostics

NeuraSignal

Riverain Technologies, LLC

Philips

Microsoft

Viz.ai

RapidAI

Canon Medical

Enlitic

BioMind

ANNALISE-AI PTY LTD

icometrix

KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）

Artificial Intelligence Diagnostics Segment by Type

Services

Software

Hardware

Artificial Intelligence Diagnostics Segment by Application

Radiology

Oncology

Neurology

Cardiology

Chest & Lungs

Others

Artificial Intelligence Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Intelligence Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Artificial Intelligence Diagnostics key companies, revenue, market share, and recent developments.

3. To split the Artificial Intelligence Diagnostics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Artificial Intelligence Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Intelligence Diagnostics significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Intelligence Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence Diagnostics industry.

Chapter 3: Detailed analysis of Artificial Intelligence Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Artificial Intelligence Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Artificial Intelligence Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Intelligence Diagnostics Industry Trends Table 2. Artificial Intelligence Diagnostics Industry Drivers Table 3. Artificial Intelligence Diagnostics Industry Opportunities and Challenges Table 4. Artificial Intelligence Diagnostics Industry Restraints Table 5. Global Artificial Intelligence Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Intelligence Diagnostics Revenue Share by Company (2021-2026) Table 7. Global Artificial Intelligence Diagnostics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Artificial Intelligence Diagnostics Key Company Manufacturing Base & Headquarters Table 9. Global Artificial Intelligence Diagnostics Company, Product Type & Application Table 10. Global Artificial Intelligence Diagnostics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Artificial Intelligence Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Services Table 15. Significant Companies of Software Table 16. Significant Companies of Hardware Table 17. Global Artificial Intelligence Diagnostics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Artificial Intelligence Diagnostics Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Artificial Intelligence Diagnostics Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Artificial Intelligence Diagnostics Sales Value Share by Type (2021-2026) Table 21. Global Artificial Intelligence Diagnostics Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Radiology Table 23. Significant Companies of Oncology Table 24. Significant Companies of Neurology Table 25. Significant Companies of Cardiology Table 26. Significant Companies of Chest & Lungs Table 27. Significant Companies of Others Table 28. Global Artificial Intelligence Diagnostics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Artificial Intelligence Diagnostics Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Artificial Intelligence Diagnostics Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Artificial Intelligence Diagnostics Sales Value Share by Application (2021-2026) Table 32. Global Artificial Intelligence Diagnostics Sales Value Share by Application (2027-2032) Table 33. Global Artificial Intelligence Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Artificial Intelligence Diagnostics Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Artificial Intelligence Diagnostics Sales Value Share by Region (2021-2026) Table 36. Global Artificial Intelligence Diagnostics Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Artificial Intelligence Diagnostics Sales Value Share by Region (2027-2032) Table 38. Global Artificial Intelligence Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Artificial Intelligence Diagnostics Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Artificial Intelligence Diagnostics Sales Value Market Share by Country (2021-2026) Table 41. Global Artificial Intelligence Diagnostics Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Artificial Intelligence Diagnostics Sales Value Market Share by Country (2027-2032) Table 43. Butterfly Network Company Information Table 44. Butterfly Network Business Overview Table 45. Butterfly Network Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Butterfly Network Artificial Intelligence Diagnostics Product Portfolio Table 47. Butterfly Network Recent Development Table 48. Merative Company Information Table 49. Merative Business Overview Table 50. Merative Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Merative Artificial Intelligence Diagnostics Product Portfolio Table 52. Merative Recent Development Table 53. Tempus Company Information Table 54. Tempus Business Overview Table 55. Tempus Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Tempus Artificial Intelligence Diagnostics Product Portfolio Table 57. Tempus Recent Development Table 58. RetinAi Company Information Table 59. RetinAi Business Overview Table 60. RetinAi Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. RetinAi Artificial Intelligence Diagnostics Product Portfolio Table 62. RetinAi Recent Development Table 63. Nanox Company Information Table 64. Nanox Business Overview Table 65. Nanox Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Nanox Artificial Intelligence Diagnostics Product Portfolio Table 67. Nanox Recent Development Table 68. Lunit Company Information Table 69. Lunit Business Overview Table 70. Lunit Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Lunit Artificial Intelligence Diagnostics Product Portfolio Table 72. Lunit Recent Development Table 73. DiA Imaging Company Information Table 74. DiA Imaging Business Overview Table 75. DiA Imaging Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. DiA Imaging Artificial Intelligence Diagnostics Product Portfolio Table 77. DiA Imaging Recent Development Table 78. Subtle Medical Company Information Table 79. Subtle Medical Business Overview Table 80. Subtle Medical Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Subtle Medical Artificial Intelligence Diagnostics Product Portfolio Table 82. Subtle Medical Recent Development Table 83. BrainMiner Company Information Table 84. BrainMiner Business Overview Table 85. BrainMiner Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. BrainMiner Artificial Intelligence Diagnostics Product Portfolio Table 87. BrainMiner Recent Development Table 88. GE Company Information Table 89. GE Business Overview Table 90. GE Artificial Intelligence Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GE Artificial Intelligence Diagnostics Product Portfolio Table 92. GE Recent Development Table 93. Siemens Company Information Table 94. Siemens Business Overview Table 95. Siemens Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Siemens Artificial Intelligence Diagnostics Product Portfolio Table 97. Siemens Recent Development Table 98. Aidoc Company Information Table 99. Aidoc Business Overview Table 100. Aidoc Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Aidoc Artificial Intelligence Diagnostics Product Portfolio Table 102. Aidoc Recent Development Table 103. Imagen Technologies, Inc. Company Information Table 104. Imagen Technologies, Inc. Business Overview Table 105. Imagen Technologies, Inc. Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Imagen Technologies, Inc. Artificial Intelligence Diagnostics Product Portfolio Table 107. Imagen Technologies, Inc. Recent Development Table 108. VUNO, Inc. Company Information Table 109. VUNO, Inc. Business Overview Table 110. VUNO, Inc. Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. VUNO, Inc. Artificial Intelligence Diagnostics Product Portfolio Table 112. VUNO, Inc. Recent Development Table 113. Digital Diagnostics Company Information Table 114. Digital Diagnostics Business Overview Table 115. Digital Diagnostics Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Digital Diagnostics Artificial Intelligence Diagnostics Product Portfolio Table 117. Digital Diagnostics Recent Development Table 118. NeuraSignal Company Information Table 119. NeuraSignal Business Overview Table 120. NeuraSignal Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. NeuraSignal Artificial Intelligence Diagnostics Product Portfolio Table 122. NeuraSignal Recent Development Table 123. Riverain Technologies, LLC Company Information Table 124. Riverain Technologies, LLC Business Overview Table 125. Riverain Technologies, LLC Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Riverain Technologies, LLC Artificial Intelligence Diagnostics Product Portfolio Table 127. Riverain Technologies, LLC Recent Development Table 128. Philips Company Information Table 129. Philips Business Overview Table 130. Philips Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Philips Artificial Intelligence Diagnostics Product Portfolio Table 132. Philips Recent Development Table 133. Microsoft Company Information Table 134. Microsoft Business Overview Table 135. Microsoft Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Microsoft Artificial Intelligence Diagnostics Product Portfolio Table 137. Microsoft Recent Development Table 138. Viz.ai Company Information Table 139. Viz.ai Business Overview Table 140. Viz.ai Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Viz.ai Artificial Intelligence Diagnostics Product Portfolio Table 142. Viz.ai Recent Development Table 143. RapidAI Company Information Table 144. RapidAI Business Overview Table 145. RapidAI Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. RapidAI Artificial Intelligence Diagnostics Product Portfolio Table 147. RapidAI Recent Development Table 148. Canon Medical Company Information Table 149. Canon Medical Business Overview Table 150. Canon Medical Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Canon Medical Artificial Intelligence Diagnostics Product Portfolio Table 152. Canon Medical Recent Development Table 153. Enlitic Company Information Table 154. Enlitic Business Overview Table 155. Enlitic Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Enlitic Artificial Intelligence Diagnostics Product Portfolio Table 157. Enlitic Recent Development Table 158. BioMind Company Information Table 159. BioMind Business Overview Table 160. BioMind Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. BioMind Artificial Intelligence Diagnostics Product Portfolio Table 162. BioMind Recent Development Table 163. ANNALISE-AI PTY LTD Company Information Table 164. ANNALISE-AI PTY LTD Business Overview Table 165. ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Product Portfolio Table 167. ANNALISE-AI PTY LTD Recent Development Table 168. icometrix Company Information Table 169. icometrix Business Overview Table 170. icometrix Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. icometrix Artificial Intelligence Diagnostics Product Portfolio Table 172. icometrix Recent Development Table 173. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Company Information Table 174. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Business Overview Table 175. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Artificial Intelligence Diagnostics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Artificial Intelligence Diagnostics Product Portfolio Table 177. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Recent Development Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Artificial Intelligence Diagnostics Product Image Figure 2. Global Artificial Intelligence Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence Diagnostics Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Intelligence Diagnostics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Services Image Figure 8. Software Image Figure 9. Hardware Image Figure 10. Global Artificial Intelligence Diagnostics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Artificial Intelligence Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Artificial Intelligence Diagnostics Sales Value Share by Type (2021-2032) Figure 13. Radiology Image Figure 14. Oncology Image Figure 15. Neurology Image Figure 16. Cardiology Image Figure 17. Chest & Lungs Image Figure 18. Others Image Figure 19. Global Artificial Intelligence Diagnostics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Artificial Intelligence Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Artificial Intelligence Diagnostics Sales Value Share by Application (2021-2032) Figure 22. Global Artificial Intelligence Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Artificial Intelligence Diagnostics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Artificial Intelligence Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 25. North America Artificial Intelligence Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Artificial Intelligence Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Artificial Intelligence Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Artificial Intelligence Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Artificial Intelligence Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Artificial Intelligence Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 31. South America Artificial Intelligence Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Artificial Intelligence Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Artificial Intelligence Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Services
  • Software
  • Hardware
Applications
  • Radiology
  • Oncology
  • Neurology
  • Cardiology
  • Chest & Lungs
  • Others
Companies covered
  • Butterfly Network
  • Merative
  • Tempus
  • RetinAi
  • Nanox
  • Lunit
  • DiA Imaging
  • Subtle Medical
  • BrainMiner
  • GE
  • Siemens
  • Aidoc
  • Imagen Technologies, Inc.
  • VUNO, Inc.
  • Digital Diagnostics
  • NeuraSignal
  • Riverain Technologies, LLC
  • Philips
  • Microsoft
  • Viz.ai
  • RapidAI
  • Canon Medical
  • Enlitic
  • BioMind
  • ANNALISE-AI PTY LTD
  • icometrix
  • KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Intelligence Diagnostics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Intelligence Diagnostics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Artificial Intelligence Diagnostics Market Dynamics
  1. 2.1 Artificial Intelligence Diagnostics Industry Trends
  2. 2.2 Artificial Intelligence Diagnostics Industry Drivers
  3. 2.3 Artificial Intelligence Diagnostics Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence Diagnostics Industry Restraints
3 Artificial Intelligence Diagnostics Market by Company
  1. 3.1 Global Artificial Intelligence Diagnostics Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Intelligence Diagnostics Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Intelligence Diagnostics Company Ranking (2024-2026)
  4. 3.4 Global Artificial Intelligence Diagnostics Company Manufacturing Base and Headquarters
  5. 3.5 Global Artificial Intelligence Diagnostics Company Product Type and Application
  6. 3.6 Global Artificial Intelligence Diagnostics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Artificial Intelligence Diagnostics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Artificial Intelligence Diagnostics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Artificial Intelligence Diagnostics Market by Type
  1. 4.1 Artificial Intelligence Diagnostics Type Introduction
  2. 4.1.1 Services
  3. 4.1.2 Software
  4. 4.1.3 Hardware
  5. 4.2 Global Artificial Intelligence Diagnostics Sales Value by Type
  6. 4.2.1 Global Artificial Intelligence Diagnostics Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Artificial Intelligence Diagnostics Sales Value by Type (2021-2032)
  8. 4.2.3 Global Artificial Intelligence Diagnostics Sales Value Share by Type (2021-2032)
5 Artificial Intelligence Diagnostics Market by Application
  1. 5.1 Artificial Intelligence Diagnostics Application Introduction
  2. 5.1.1 Radiology
  3. 5.1.2 Oncology
  4. 5.1.3 Neurology
  5. 5.1.4 Cardiology
  6. 5.1.5 Chest & Lungs
  7. 5.1.6 Others
  8. 5.2 Global Artificial Intelligence Diagnostics Sales Value by Application
  9. 5.2.1 Global Artificial Intelligence Diagnostics Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Artificial Intelligence Diagnostics Sales Value by Application (2021-2032)
  11. 5.2.3 Global Artificial Intelligence Diagnostics Sales Value Share by Application (2021-2032)
6 Artificial Intelligence Diagnostics Regional Value Analysis
  1. 6.1 Global Artificial Intelligence Diagnostics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Intelligence Diagnostics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Artificial Intelligence Diagnostics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Artificial Intelligence Diagnostics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Intelligence Diagnostics Sales Value (2021-2032)
  7. 6.3.2 North America Artificial Intelligence Diagnostics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Artificial Intelligence Diagnostics Sales Value (2021-2032)
  10. 6.4.2 Europe Artificial Intelligence Diagnostics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Artificial Intelligence Diagnostics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Artificial Intelligence Diagnostics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Artificial Intelligence Diagnostics Sales Value (2021-2032)
  16. 6.6.2 South America Artificial Intelligence Diagnostics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Artificial Intelligence Diagnostics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Artificial Intelligence Diagnostics Sales Value Share by Country, 2025 VS 2032
7 Artificial Intelligence Diagnostics Country-level Value Analysis
  1. 7.1 Global Artificial Intelligence Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Intelligence Diagnostics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Artificial Intelligence Diagnostics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Artificial Intelligence Diagnostics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Artificial Intelligence Diagnostics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Artificial Intelligence Diagnostics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Artificial Intelligence Diagnostics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Butterfly Network
  2. 8.1.1 Butterfly Network Company Information
  3. 8.1.2 Butterfly Network Business Overview
  4. 8.1.3 Butterfly Network Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Butterfly Network Artificial Intelligence Diagnostics Product Portfolio
  6. 8.1.5 Butterfly Network Recent Developments
  7. 8.2 Merative
  8. 8.2.1 Merative Company Information
  9. 8.2.2 Merative Business Overview
  10. 8.2.3 Merative Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merative Artificial Intelligence Diagnostics Product Portfolio
  12. 8.2.5 Merative Recent Developments
  13. 8.3 Tempus
  14. 8.3.1 Tempus Company Information
  15. 8.3.2 Tempus Business Overview
  16. 8.3.3 Tempus Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tempus Artificial Intelligence Diagnostics Product Portfolio
  18. 8.3.5 Tempus Recent Developments
  19. 8.4 RetinAi
  20. 8.4.1 RetinAi Company Information
  21. 8.4.2 RetinAi Business Overview
  22. 8.4.3 RetinAi Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 RetinAi Artificial Intelligence Diagnostics Product Portfolio
  24. 8.4.5 RetinAi Recent Developments
  25. 8.5 Nanox
  26. 8.5.1 Nanox Company Information
  27. 8.5.2 Nanox Business Overview
  28. 8.5.3 Nanox Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nanox Artificial Intelligence Diagnostics Product Portfolio
  30. 8.5.5 Nanox Recent Developments
  31. 8.6 Lunit
  32. 8.6.1 Lunit Company Information
  33. 8.6.2 Lunit Business Overview
  34. 8.6.3 Lunit Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lunit Artificial Intelligence Diagnostics Product Portfolio
  36. 8.6.5 Lunit Recent Developments
  37. 8.7 DiA Imaging
  38. 8.7.1 DiA Imaging Company Information
  39. 8.7.2 DiA Imaging Business Overview
  40. 8.7.3 DiA Imaging Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DiA Imaging Artificial Intelligence Diagnostics Product Portfolio
  42. 8.7.5 DiA Imaging Recent Developments
  43. 8.8 Subtle Medical
  44. 8.8.1 Subtle Medical Company Information
  45. 8.8.2 Subtle Medical Business Overview
  46. 8.8.3 Subtle Medical Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Subtle Medical Artificial Intelligence Diagnostics Product Portfolio
  48. 8.8.5 Subtle Medical Recent Developments
  49. 8.9 BrainMiner
  50. 8.9.1 BrainMiner Company Information
  51. 8.9.2 BrainMiner Business Overview
  52. 8.9.3 BrainMiner Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BrainMiner Artificial Intelligence Diagnostics Product Portfolio
  54. 8.9.5 BrainMiner Recent Developments
  55. 8.10 GE
  56. 8.10.1 GE Company Information
  57. 8.10.2 GE Business Overview
  58. 8.10.3 GE Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GE Artificial Intelligence Diagnostics Product Portfolio
  60. 8.10.5 GE Recent Developments
  61. 8.11 Siemens
  62. 8.11.1 Siemens Company Information
  63. 8.11.2 Siemens Business Overview
  64. 8.11.3 Siemens Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Siemens Artificial Intelligence Diagnostics Product Portfolio
  66. 8.11.5 Siemens Recent Developments
  67. 8.12 Aidoc
  68. 8.12.1 Aidoc Company Information
  69. 8.12.2 Aidoc Business Overview
  70. 8.12.3 Aidoc Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aidoc Artificial Intelligence Diagnostics Product Portfolio
  72. 8.12.5 Aidoc Recent Developments
  73. 8.13 Imagen Technologies, Inc.
  74. 8.13.1 Imagen Technologies, Inc. Company Information
  75. 8.13.2 Imagen Technologies, Inc. Business Overview
  76. 8.13.3 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Product Portfolio
  78. 8.13.5 Imagen Technologies, Inc. Recent Developments
  79. 8.14 VUNO, Inc.
  80. 8.14.1 VUNO, Inc. Company Information
  81. 8.14.2 VUNO, Inc. Business Overview
  82. 8.14.3 VUNO, Inc. Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 VUNO, Inc. Artificial Intelligence Diagnostics Product Portfolio
  84. 8.14.5 VUNO, Inc. Recent Developments
  85. 8.15 Digital Diagnostics
  86. 8.15.1 Digital Diagnostics Company Information
  87. 8.15.2 Digital Diagnostics Business Overview
  88. 8.15.3 Digital Diagnostics Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Digital Diagnostics Artificial Intelligence Diagnostics Product Portfolio
  90. 8.15.5 Digital Diagnostics Recent Developments
  91. 8.16 NeuraSignal
  92. 8.16.1 NeuraSignal Company Information
  93. 8.16.2 NeuraSignal Business Overview
  94. 8.16.3 NeuraSignal Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  95. 8.16.4 NeuraSignal Artificial Intelligence Diagnostics Product Portfolio
  96. 8.16.5 NeuraSignal Recent Developments
  97. 8.17 Riverain Technologies, LLC
  98. 8.17.1 Riverain Technologies, LLC Company Information
  99. 8.17.2 Riverain Technologies, LLC Business Overview
  100. 8.17.3 Riverain Technologies, LLC Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Riverain Technologies, LLC Artificial Intelligence Diagnostics Product Portfolio
  102. 8.17.5 Riverain Technologies, LLC Recent Developments
  103. 8.18 Philips
  104. 8.18.1 Philips Company Information
  105. 8.18.2 Philips Business Overview
  106. 8.18.3 Philips Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Philips Artificial Intelligence Diagnostics Product Portfolio
  108. 8.18.5 Philips Recent Developments
  109. 8.19 Microsoft
  110. 8.19.1 Microsoft Company Information
  111. 8.19.2 Microsoft Business Overview
  112. 8.19.3 Microsoft Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Microsoft Artificial Intelligence Diagnostics Product Portfolio
  114. 8.19.5 Microsoft Recent Developments
  115. 8.20 Viz.ai
  116. 8.20.1 Viz.ai Company Information
  117. 8.20.2 Viz.ai Business Overview
  118. 8.20.3 Viz.ai Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Viz.ai Artificial Intelligence Diagnostics Product Portfolio
  120. 8.20.5 Viz.ai Recent Developments
  121. 8.21 RapidAI
  122. 8.21.1 RapidAI Company Information
  123. 8.21.2 RapidAI Business Overview
  124. 8.21.3 RapidAI Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  125. 8.21.4 RapidAI Artificial Intelligence Diagnostics Product Portfolio
  126. 8.21.5 RapidAI Recent Developments
  127. 8.22 Canon Medical
  128. 8.22.1 Canon Medical Company Information
  129. 8.22.2 Canon Medical Business Overview
  130. 8.22.3 Canon Medical Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Canon Medical Artificial Intelligence Diagnostics Product Portfolio
  132. 8.22.5 Canon Medical Recent Developments
  133. 8.23 Enlitic
  134. 8.23.1 Enlitic Company Information
  135. 8.23.2 Enlitic Business Overview
  136. 8.23.3 Enlitic Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Enlitic Artificial Intelligence Diagnostics Product Portfolio
  138. 8.23.5 Enlitic Recent Developments
  139. 8.24 BioMind
  140. 8.24.1 BioMind Company Information
  141. 8.24.2 BioMind Business Overview
  142. 8.24.3 BioMind Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  143. 8.24.4 BioMind Artificial Intelligence Diagnostics Product Portfolio
  144. 8.24.5 BioMind Recent Developments
  145. 8.25 ANNALISE-AI PTY LTD
  146. 8.25.1 ANNALISE-AI PTY LTD Company Information
  147. 8.25.2 ANNALISE-AI PTY LTD Business Overview
  148. 8.25.3 ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  149. 8.25.4 ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Product Portfolio
  150. 8.25.5 ANNALISE-AI PTY LTD Recent Developments
  151. 8.26 icometrix
  152. 8.26.1 icometrix Company Information
  153. 8.26.2 icometrix Business Overview
  154. 8.26.3 icometrix Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  155. 8.26.4 icometrix Artificial Intelligence Diagnostics Product Portfolio
  156. 8.26.5 icometrix Recent Developments
  157. 8.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）
  158. 8.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Company Information
  159. 8.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Business Overview
  160. 8.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  161. 8.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Artificial Intelligence Diagnostics Product Portfolio
  162. 8.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst